Bolt Biotherapeutics

Positive topline data for Bolt’s BDC-1001 in HER2 solid tumours
Clinical Trials Arena
Fri, 03/31/23 - 10:22 am
Bolt Biotherapeutics
BDC-1001
solid tumors
Roche
Bristol Myers Squibb
IPO tracker: 2021 gets started with a flurry of new offerings
Endpoints
Mon, 01/25/21 - 10:43 am
IPOs
Sana Biotechnology
Sensei Biotherapeutics
Bolt Biotherapeutics
Immunocore
Terns Pharmaceuticals
Pharvaris
Vor Biopharma
Adagene
NexImmune
Biophytis
Gracell Biotechnologies
Cullinan Oncology
Bolt Biotherapeutics nabs $93.5M to push Provenge inventor's new idea deeper in the clinic
Endpoints
Wed, 07/1/20 - 11:19 am
Bolt Biotherapeutics
funding
Provenge
solid tumors
Bolt Bio preps clinical trials of immune-stimulating cancer drug in stubborn solid tumors
Fierce Biotech
Mon, 11/11/19 - 10:44 am
Bolt Biotherapeutics
immuno-oncology
clinical trials
cancer